Autor: |
Radeva L; Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria., Yordanov Y; Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria., Spassova I; Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Kovacheva D; Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Tibi IP; Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria., Zaharieva MM; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Kaleva M; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Najdenski H; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Petrov PD; Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria., Tzankova V; Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria., Yoncheva K; Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. |
Abstrakt: |
Resveratrol could be applied in wound healing therapies because of its antioxidant, anti-inflammatory and antibacterial effects. However, the main limitation of resveratrol is its low aqueous solubility. In this study, resveratrol was included in hydroxypropyl-β-cyclodextrin complexes and further formulated in Pluronic F-127 hydrogels for wound treatment therapy. IR-spectroscopy and XRD analysis confirmed the successful incorporation of resveratrol into complexes. The wound-healing ability of these complexes was estimated by a scratch assay on fibroblasts, which showed a tendency for improvement of the effect of resveratrol after complexation. The antimicrobial activity of resveratrol in aqueous dispersion and in the complexes was evaluated on methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli , and Candida albicans strains. The results revealed a twofold decrease in the MIC and stronger inhibition of the metabolic activity of MRSA after treatment with resveratrol in the complexes compared to the suspended drug. Furthermore, the complexes were included in Pluronic hydrogel, which provided efficient drug release and appropriate viscoelastic properties. The formulated hydrogel showed excellent biocompatibility which was confirmed via skin irritation test on rabbits. In conclusion, Pluronic hydrogel containing resveratrol included in hydroxypropyl-β-cyclodextrin complexes is a promising topical formulation for further studies directed at wound therapy. |